Objectives: A strain of the opportunistic pathogenic yeast Candida lusitaniae was genetically engineered for fulllength replacement of the FKS1 gene encoding the target of echinocandin antifungals in order to assess the impact of FKS mutations on echinocandin resistance and reduced echinocandin susceptibility (RES).
Introduction
The echinocandins caspofungin, micafungin and anidulafungin are structurally related acylated cyclic hexapeptides having concentration-dependent antifungal activity against Candida spp. and Aspergillus spp. 1 They are now the first-line treatment for invasive candidiasis in most patients. They act as non-competitive inhibitors of the fungal b(1,3)-glucan synthase, thus disturbing and inhibiting fungal cell wall synthesis.
1 b(1,3)-Glucan synthase consists of a cytoplasmic regulatory protein and membrane-bound Fksp catalytic subunits, which may be encoded according to the fungal species by several FKS paralogue genes. In yeast species belonging to the CTG clade of Candida, e.g. Candida albicans, the FKS1 gene that encodes the catalytic subunit targeted by echinocandins is essential, 2 whereas in Candida glabrata 3 and Saccharomyces cerevisiae, 4 the catalytic subunits are encoded by the FKS1 and FKS2 genes, which are at least partially functionally redundant. Besides a tolerance phenomenon mediated by calcineurin, high-osmolarity glycerol (HOG) and protein kinase C (PKC) cellular stress response pathways leading to increased chitin synthesis 5 and cell wall remodelling, 6 the main mechanism of echinocandin resistance involves non-synonymous mutations of the FKS genes, which decrease the binding affinity of the target protein to the echinocandin inhibitor. 7 The two so-called hotspot (HS) regions, HS1 and HS2, were identified as the regions of the FKS genes containing all resistance mutations. 8 However, in clinical strains resistant to echinocandins, the HS1 and HS2 regions are the only regions that have been screened for genetic variability because of the large size of the FKS genes (6 kb). Accordingly, very little information is known about the genetic variability of FKS regions outside the HSs and about their possible contribution to echinocandin resistance. The use of next-generation sequencing for clinical molecular diagnosis in the near future is expected to provide extensive information about the overall genetic variability of FKS genes. This will raise the question of the contribution of new genetic polymorphisms to the resistance or reduced susceptibility to echinocandins (RES), as reported for a third HS region identified in the FKS1 gene of S. cerevisiae and C. glabrata. 9 Generally, the impact of a missense mutation is demonstrated at the molecular level by expressing an allele containing the suspected mutation in a biological model, such as S. cerevisiae. However, because of the large size of the FKS genes, the genetic models developed so far have been restricted to the extrachromosomal expression of chimeric S. cerevisiae FKS genes recombined with the HS1 region that is suspected of being involved in resistance. [10] [11] [12] [13] In this work, we report the development of a new expression system based on the replacement of the full-length FKS1 allele in Candida (teleomorph Clavispora) lusitaniae, an opportunistic pathogenic yeast belonging to the CTG clade. Its haploid genome can be genetically engineered easily. 14, 15 This recently allowed us to develop an expression system to screen the impact of mutations in the essential gene ERG11 on azole antifungal susceptibility. 16 Since deletion of FKS1 in C. lusitaniae is not viable, the replacement of FKS1 was based on the recombination of two linear DNA fragments encompassing the entire ORF and overlapping a small 40 bp region where SNPs or small indels of interest were inserted. Correct integration at FKS1 was selected by the functional reconstitution of auxotrophic markers implanted in the upstream and downstream regions of FKS1. As a proof of concept, we successfully expressed FKS mutations in C. lusitaniae that have already been described in clinical isolates of C. albicans, C. glabrata and Candida parapsilosis.
Materials and methods

Yeast strains and culture conditions
The different strains used and constructed in this study are listed in Table 1 
Antifungal susceptibility testing
In vitro caspofungin susceptibility was determined using Etest (bioMérieux, France) according to the manufacturer's instructions. For each FKS mutation expressed in C. lusitaniae, caspofungin MIC was determined for eight prototroph clones selected after transformation and confirmed for having acquired the mutation of interest by nucleotide sequencing. For the WT strain and clones transformed with an FKS1 allele conferring RES (F634V and P642A), MIC was confirmed by the CLSI broth microdilution method 
DNA extraction, PCR amplifications and nucleotide sequencing
Genomic DNA was extracted by a glass bead method for yeast cell disruption, as previously described.
14 The high-fidelity DNA polymerase Pfu (Promega) was used to amplify DNA fragments by PCR for cloning steps and for overlapping PCR. Routine PCRs were performed with GoTaq DNA polymerase or GoTaq Long for PCR targets up to 5 kb (Promega), as recommended by the supplier. All primers used in this study (Table S1 , available as Supplementary data at JAC Online) were synthesized by Eurofins MWG Operon (Europe). When required, PCR products were sequenced by Eurofins MWG Operon using the BigDye Terminator v3.1 kit (Applied Biosystems).
Molecular constructions and yeast transformations
To construct the DNA cassettes, DNA fragments were generated by PCR using primers having a 15 bp overlap homology at their ends and were assembled and cloned using the In-Fusion V R HD Cloning Kit (Clontech), as previously described. 16 Yeast strains were transformed by electroporation, 15 slightly modified by adding 1 M sorbitol to the lithium acetate buffer, using 1 to 2 lg of transforming DNA per experiment. Prototrophic transformants were selected on YNBS selective medium after 3 days of incubation at 35 C.
Southern blotting
Approximately 10 lg of C. lusitaniae DNA was digested with the appropriate restriction enzyme, separated by electrophoresis in a 1% agarose gel and transferred onto nylon membranes (Hybond N!; Roche Molecular Biochemicals). Hybridization was carried out with digoxigenin (DIG)-labelled probes synthesized with a PCR DIG probe synthesis kit (Roche Molecular Biochemicals), as specified by the supplier.
Results
Accurate annotation of the FKS1 gene of C. lusitaniae
Comparison of BLAST sequences using the Fks1 proteins of C. albicans and C. glabrata allowed identification of the FKS1 gene Caspofungin resistance and FKS mutations JAC of C. lusitaniae (GenBank accession number OVF07437) in the genome of the CBS 6936 strain (GenBank accession number LYUB02000000 17 ) on scaffold 13 (locus tag A9F13_13g01430). The intronless ORF of 5661 nt encodes a predicted protein of 1886 amino acids showing 82.9% and 71.8% identity with the orthologous protein of C. albicans (strain SC5314, GenBank accession number XP_721429) and of C. glabrata (strain CBS 138, GenBank accession number XP_446406), respectively. The genomic map surrounding the FKS1 gene of strain CBS 6936 was comparable to that of the C. lusitaniae strain ATCC 42720 (GenBank accession number NW_003101577, scaffold 2, FKS1 encompasses CLUG_01697 to CLUG_01702 due to sequence errors). Synteny with C. albicans SC5314 was conserved. A gene encoding the putative eukaryotic translation initiation factor 2A is located 2221 bp upstream of the C. lusitaniae FKS1 gene and a gene encoding a putative a-1,6-mannosyltransferase is located 382 bp downstream.
Design of a C. lusitaniae strain for the homologous expression of full-length mutated FKS1 alleles An initial difficulty for replacing the FKS1 allele in C. lusitaniae is that the gene is essential, as in C. albicans. 2 Attempts to obtain a deletion mutant in C. lusitaniae have failed until now, in spite of generally having a good rate of homologous recombination during transformation experiments, from 25% to 100% according to the locus targeted.
14, 15 The haploidy of C. lusitaniae represents an additional obstacle for working with essential genes.
A second difficulty is the large size of FKS1, which requires the generation and manipulation of large DNA fragments in vitro; in the present case, 5661 bp for the ORF, plus 0.4 kb for each 5 0 -UTR and 3 0 -UTR (where UTR stands for untranslated transcribed region), and 1.5 kb for the functional genetic marker allowing the selection of the yeasts having achieved FKS1 allele replacement. Using the 'split-marker' strategy developed in S. cerevisiae, 20 we conducted a preliminary experiment in C. lusitaniae where we successfully repaired a large 990 bp deletion in the URA3 gene of a mutant strain after transformation with two independent linear DNA fragments. Each fragment carried half of the URA3 coding region, and had extremities allowing the fragments to first recombine with each other before integrating the locus by recombination with the chromosomal regions flanking the deletion (data not shown). We therefore decided to replace the FKS1 allele with two recombinant DNA fragments, targeting their integration at the FKS1 locus by the concomitant reconstitution of two auxotrophic markers in the upstream and downstream intergenic (IG) regions of FKS1 (Figure 1) .
Engineering the C. lusitaniae strain for FKS1 allele replacement
All genetic modifications were performed in the strain 6936 trp1D, ura3D. First, the C. lusitaniae TRP1 gene was integrated into the FKS1 upstream IG region of strain 6936 trp1D, ura3D (Figure 1a) , using a DNA cassette made of the TRP1 gene with its own 5 0 and 3 0 regulatory regions flanked on both sides by DNA fragments (400 bp) homologous to the FKS1 upstream IG region. One transformant, named F1 TRP1, ura3D, was selected. Second, according to the same principle, the URA3 gene was introduced into the FKS1 Accoceberry et al.
downstream IG region of the strain F1 TRP1, ura3D (Figure 1b) , leading to the selection of a prototrophic transformant F1 TRP1, URA3. Third, the 3 0 half part of the TRP1 gene was removed from the strain F1 TRP1, URA3 by replacing TRP1 with a DNA cassette made of the 5 0 half part of TRP1 flanked by DNA fragments homologous to the FKS1 upstream IG region (Figure 1c) . Tryptophan auxotrophic clones were selected by 5-fluoroanthranilic acid resistance and one of them, named F1 trp1D3 0 , URA3, was retained for further manipulation. Fourth, using the same strategy, the 5 0 half part of the URA3 gene was removed from the strain F1 trp1D3 0 , URA3, to yield the strain F1 trp1D3 0 , ura3D5 0 , which was selected among the clones resistant to 5-fluoroorotic acid (Figure 1d) .
At each step of the molecular modifications, correct targeted integration of the different DNA cassettes was verified by PCR and nucleotide sequencing. The genotype of the selected transformants (Table 1) was also verified by Southern blotting analysis of EcoRV-digested genomic DNA using the 3 0 TRP1, 5 0 URA3, 3 0 URA3 and FKS1 probes ( Figure S1 ) to exclude clones exhibiting any additional or incorrect integration events. Finally, we verified that the molecular modifications achieved in the strain F1 trp1D3 0 , ura3D5 0 did not alter its susceptibility to echinocandin drugs; both CLSI and Etest methods gave a caspofungin MIC of 0.125 mg/L, which was identical to that of the WT strain CBS 6936. Accordingly, strain F1 trp1D3 0 , ura3D5 0 was used in the rest of the study for all FKS1 allele replacement experiments.
Expression of full-length mutated FKS1 alleles in C. lusitaniae
Replacement of the resident WT FKS1 allele of the strain F1 trp1D3 0 , ura3D5 0 by an FKS1 allele containing any SNP of interest was achieved by co-transformation with two recombinable DNA fragments overlapping the FKS1 gene and its regulatory sequences. To ensure their correct targeted integration at the FKS1 locus, each fragment was fused to the complementary part of one of the auxotrophic markers inserted in the upstream and downstream regions flanking FKS1. To allow crossover to take place and to reconstitute functional TRP1, FKS1 and URA3 genes, the transforming DNA fragments contained an overlapping region of 166 bp in the TRP1 region or 211 bp in the URA3 region, and 40 bp in the FKS1 region where the SNP was introduced (Figure 2 ). When the two DNA fragments were co-transformed into the F1 trp1D3 0 , ura3D5 0 strain, they recombined in cellulo to integrate the FKS1 locus, thereby allowing selection on YNBS medium of prototroph transformant yeast cells that had integrated the new FKS1 allele containing the SNP of interest. Selected clones were then screened for the presence of the point mutation by DNA sequencing and their caspofungin susceptibility pattern was determined. According to the position of the SNP of interest, 40% to 75% of the transformants tested carried the desired point mutation. The other clones were prototrophic, but the molecular events leading to integration of the DNA fragments took place outside the overlapping region where the mutation was introduced.
Proof of concept: impact of FKS mutations known to be associated with in vitro caspofungin resistance or RES Our genetic model was first challenged with three mutations previously reported in the FKS1 alleles of clinical isolates of C. albicans, resulting in amino acid changes phenylalanine to valine at position 641 (F641V) in HS1, serine to proline at position 645 (S645P) in HS1 and arginine to glycine at position 1361 (R1361G) in HS2 (Figure 3) .
Expression of the mutated FKS1 allele bearing the F634V mutation (equivalent to F641V) in the C. lusitaniae strain F1 trp1D3 0 , ura3D5 0 conferred an intermediate level of resistance to caspofungin (MIC " 1.5 mg/L), while introduction of S638P (equivalent to S645P) or R1352G (equivalent to R1361G) mutations conferred full resistance (MICs 32 mg/L; Figure 4) .
Our model was then challenged with a mutation reported in C. glabrata. Unlike other Candida species, mutations conferring resistance to caspofungin also affect FKS2, with a 2-fold greater frequency than that of FKS1 mutations. Accordingly, we introduced a mutation specific to the FKS2 gene of C. glabrata into the FKS1 gene of C. lusitaniae at the equivalent position. The mutation consisted of the deletion of a phenylalanine at position 659 (Figure 3) . Expression of the FKS1 F634del allele in C. lusitaniae resulted in an increase in caspofungin MIC from 0.125 to 32 mg/L (Figure 4) . Resulting genetic map of the FKS1 locus after FKS1 allelic exchange. The size of the overlapping regions that were used to allow crossover to take place is indicated. An SNP is represented by an asterisk.
Caspofungin resistance and FKS mutations JAC Lastly, our system was tested with the naturally occurring P660A polymorphism reported in the FKS1 alleles of all isolates of the C. parapsilosis species complex. 10 This mutation was shown to be responsible for higher MICs of all echinocandins for C. parapsilosis, compared with other Candida species (Figure 3) . 10 Introduction of the equivalent mutation P642A into the C. lusitaniae FKS1 allele gave a 6-fold increase in caspofungin MIC (0.125 to 0.75 mg/L; Figure 4 ). This confirmed the role of the P660A substitution in RES and showed that this reduced susceptibility can be transferred to other species of the CTG clade.
Discussion
The main molecular mechanism leading to resistance to echinocandins or RES is mediated by non-synonymous mutations affecting the Fksp subunits of b(1,3)-glucan synthase. 2, 8 The resistance mutations known so far are located within two HS regions. 7, 8 However, echinocandins are non-competitive inhibitors and do not interact directly with the catalytic site. This suggests that mutations outside HS regions can contribute to resistance and RES, as already shown in S. cerevisiae. One way to demonstrate the involvement of a mutation in resistance or RES is to express the mutated allele and the WT allele from which it derives in cells having an isogenic background and to compare echinocandin MICs. The S. cerevisiae expression system was based on an fks1 deletion mutant that was complemented by the expression of a WT or mutated FKS1 allele cloned in a 2l ori episomal plasmid. 8 Nucleotide modifications were introduced into the FKS allele as point mutations, or as a chimeric construction involving a S. cerevisiae FKS allele recombined with the HS region of an FKS allele suspected of conferring resistance to a clinical isolate. 8, 9, [11] [12] [13] FKS1 expression in S. cerevisiae was facilitated by the fact that an fks1D mutant is viable owing to the presence of the functionally redundant paralogue gene GSC2 (alias FKS2). 21 Functional redundancy has also been reported in the related opportunistic pathogenic yeast species, C. glabrata, 3, 22 whose prevalence of clinical isolates resistant to echinocandins has increased in recent years. 7, 23 This made allelic replacement possible at the chromosomal level in C. glabrata by integrating one FKS copy fused to an auxotrophic marker to select the transformants. 22 However, interpreting the effect of an FKS mutation on RES in C. glabrata can be hampered by the presence of the WT FKS paralogue. 3 Most of the invasive yeast infections are caused by Candida species belonging to the CTG clade, of which C. albicans is the most prevalent. This phylogenic group of yeasts is characterized by the fact that FKS1 is an essential gene whose deletion is not compensated by FKS2. 24 Engineering C. albicans to express a mutated FKS1 allele was achieved with an integrative plasmid carrying a copy of the mutated FKS1 allele designed to recombine to the chromosomal FKS1 locus. 8 However, the diploidy of C. albicans can constitute an issue for testing echinocandin resistance because of the difficulty of obtaining homozygous mutants.
To overcome the problems resulting from FKS redundancy or diploidy, we developed in this work a strain of the CTG clade haploid yeast species C. lusitaniae as an alternative model for fulllength FKS1 replacement. Several studies previously showed that echinocandin MICs were from 4-fold to 8-fold higher for C. lusitaniae than for C. albicans. 25, 26 However, most clinical isolates exhibit low echinocandin MICs with more than 90% of the isolates being inhibited by concentrations lower or equal to 1 mg/L for anidulafungin and 0.5 mg/L for caspofungin and micafungin. 27 Here, we used a strain derived from the type strain CBS 6936 of C. lusitaniae, 17 which has a low caspofungin MIC of 0.125 mg/L and whose susceptibility remained unchanged after the genetic modifications performed in both IG regions flanking the FKS1 gene. We used caspofungin because of its availability in powder form that allowed MIC determination to be performed both by the CLSI microdilution method and by Etest, notably in the case of RES.
Our expression system was challenged with known mutations reported and validated from different genes (FKS1 or FKS2), different regions (HS1 or HS2) and different Candida species. When introduced at an equivalent position into the FKS1 gene of C. lusitaniae, the FKS1 S645P and R1361G of C. albicans, 8 the latter mutation being initially discovered in the FKS1 R1361G of Candida krusei, 8 and the FKS2 F659del of C. glabrata 28 conferred high caspofungin MICs, while the FKS2 F641V of C. glabrata 29 and the FKS1 P660A of C. parapsilosis 10 conferred RES. Most importantly, the caspofungin MICs conferred to C. lusitaniae were fully comparable to those for the clinical isolates from which they were originally reported. In conclusion, we have successfully developed a C. lusitaniae strain for the expression of a single chromosomal copy of an essential FKS1 essential gene that allows any new genetic polymorphism involved in echinocandin resistance or RES in Candida species to be screened. 
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F634V S638P R1352G F634del P642A Figure 4 . Etest determination of caspofungin susceptibility of the C. lusitaniae strain F1 trp1D3 0 , ura3D5 0 expressing a WT Fks1 protein and expressing Fks1 proteins containing different amino acid substitutions. For each FKS1 allele expressed, caspofungin MIC was determined for eight independent clones after having controlled at the molecular level that they had integrated the SNP of interest. The MIC is indicated by a white arrow.
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